Prognostic value of CEACAM1 in breast cancer in situ

Please use this identifier to cite or link to this item: http://essuir.sumdu.edu.ua/handle/123456789/75201

Or use following links to share this resource in social networks: Recommend this item

Title	Prognostic value of CEACAM1 in breast cancer in situ
Authors	Lyndin, Mykola Serhiiovych Moskalenko, Roman Andriiovych Romaniuk, Anatolii Mykolaiovych Singer, B.B.
ORCID	http://orcid.org/0000-0003-4385-3903 http://orcid.org/0000-0002-2342-0337 http://orcid.org/0000-0003-2560-1382
Keywords	CEACAM1 рак молочної залози рак молочной железы breast cancer рак in situ cancer in situ DCIS
Type	Conference Papers
Date of Issue	2019
URI	http://essuir.sumdu.edu.ua/handle/123456789/75201
Publisher	Springer
License
Citation	Prognostic value of CEACAM1 in breast cancer in situ / M. Lyndin, R. Moskalenko, A. Romaniuk et al. // Virchows Archiv. European Journal of Pathology. – 2019. – Vol. 475, Suppl 1. – S. 86. – Pathology is Nice: 31th European Congress of Pathology, 7-11 September 2019, Nice Acropolis Centre, France.
Abstract	Background & Objectives: Ductal breast cancer can be divided into invasive and non-invasive types (cancer in situ – DCIS). Although there is information about molecular features of these tumours, DCIS remains none fully described pathology. Thus we need to find novel reliable diagnostic markers. One could be the сarcinoembryonic antigen related cell adhesion molecules 1 (CEACAM1). This molecule was described in diverse invasive types of cancers. The aim our study presented here was to characterise the exact expression pattern of CEACAM1 in various types of DCIS.
Appears in Collections:	Наукові видання (НН МІ)